Streptococcus Pneumoniae
Clone disseminate of rifampin-resistant S. pneumoniae found in HIV patients
Published in Medical Letter on the CDC and FDA, August 21st, 2005
According to recent research from Spain, "A total of 103 (0.7%) of 14,236 Streptococcus pneumoniae isolates collected in four Spanish hospitals from 1989 to 2003 were resistant to rifampin (MICs, 4 to 512 mcg/mL). Only sixty-one (59.2%) of these isolates were available for molecular characterization."
"Resistance was mostly related to human immunodeficiency virus (HIV) infection in adult patients and to conjunctivitis in children," reported M.J. Ferrandiz and colleagues at Institute Salud Carlos III in Madrid.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Vaccine
Adverse events reported by participants in CDC anthrax program reviewed - Fetal Loss Risk Factors
Elevated factor VII is risk factor for recurrent fetal loss - Hepatocellular Cancer
SEN virus infection not major cause of hepatocellular carcinoma - Malaria Diagnosis
Malaria screening and treatment of refugees from Cambodia described - Poliovirus Genomics and Genetics
Genomic analysis of vaccine-derived poliovirus strains reported - Acinetobacter Baumannii Outbreak
Carbapenem-resistant Acinetobacter baumannii cause of hospital outbreak - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
